Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Shandong Pharmaceutical Glass Co Ltd
Revenue
Shandong Pharmaceutical Glass Co Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Revenue
¥4.9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
12%
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Revenue
¥13.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Revenue
¥4.4B
|
CAGR 3-Years
16%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
Winner Medical Co Ltd
SZSE:300888
|
Revenue
¥11.4B
|
CAGR 3-Years
35%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Revenue
¥3.9B
|
CAGR 3-Years
21%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
Autek China Inc
SZSE:300595
|
Revenue
¥1.7B
|
CAGR 3-Years
26%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
See Also
What is Shandong Pharmaceutical Glass Co Ltd's Revenue?
Revenue
4.9B
CNY
Based on the financial report for Sep 30, 2023, Shandong Pharmaceutical Glass Co Ltd's Revenue amounts to 4.9B CNY.
What is Shandong Pharmaceutical Glass Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
12%
Over the last year, the Revenue growth was 20%. The average annual Revenue growth rates for Shandong Pharmaceutical Glass Co Ltd have been 16% over the past three years , 14% over the past five years , and 12% over the past ten years .